The Occurrence or Fibrillary Glomerulonephritis in Patients with Diabetes Mellitus May Not Be Coincidental: A Report of Four Cases

Table 1

Clinical, biochemical, and histologic data from patients with fibrillary glomerulonephritis.

No.	Sex	Age	SCr	Proteinuria	Haematuria	TCh	LDL	TGC	Ua	LM	SG	IF	EM (fibrils)	DM	IS
1	M	55	1.02	13.52	Yes	319	49	165	4.21	MG	1/14	IgG, C, and κ	15–20 nm	Yes	Yes
2	F	48	0.93	4.58	Yes	178	—	117	6.35	MG	7/18	IgG, IgM, λ, and C	17 nm	Yes	No
3	M	45	1.85	9.33	No	228	—	514	6.21	MP	3/15	IgG, κ, and λ	18.22 nm	Yes	No
4	M	55	1.54	2.66	sí	194	108	40	5.2	GSF	4/11	IgG, λ, and C	21–25 nm	Yes	No

SCr: serum creatinine at diagnosis in mg/dL; Proteinuria: urine protein at diagnosis in g/day; Haematuria: microhematuria; TCh: total cholesterol; LDL: LDL cholesterol; TGC: triglycerides; Ua: uric acid; LM: light microscopy; SG: sclerotic glomeruli; EM: electron microscopy; IF: immunofluorescence; DM: diabetes mellitus; IS: immunosuppressive treatment; MG: membranous glomerulonephritis; MP: membranoproliferative glomerulonephritis; EFG: focal and segmental glomerulosclerosis.